Search

Roivant Sciences Ltd

Gesloten

SectorGezondheidszorg

34.56 1.89

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

33.61

Max

34.85

Belangrijke statistieken

By Trading Economics

Inkomsten

669M

356M

Verkoop

521K

2.5M

Winstmarge

14,116.825

Werknemers

721

EBITDA

744M

455M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+3.5% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

4.7B

25B

Vorige openingsprijs

32.67

Vorige sluitingsprijs

34.56

Nieuwssentiment

By Acuity

24%

76%

59 / 342 Rangschikking in Healthcare

Roivant Sciences Ltd Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

16 jul 2026, 23:52 UTC

Social Media
News

Netflix Inc. shares fell in after-hours trading following Q2 results. Revenue of $12.56 billion missed expectations, and guidance for 2026 was narrowed lower.

16 jul 2026, 23:46 UTC

News

Paychex declared a quarterly dividend of $1.19 per share, payable August 28, contributing to positive sentiment as shares rise in after-market trading.

16 jul 2026, 23:46 UTC

ETF Constituents
News
Correlated Moves

Vanguard Growth ETF declines after-hours, impacted by Netflix's drop and broader Nasdaq 100 downturn amid rising inflation concerns and central bank comments.

16 jul 2026, 23:41 UTC

News
Correlated Moves

Lam Research Corp shares are lower in after-market trading amid a sector-wide selloff following TSMC's capital expenditure announcement and bearish sentiment from options traders.

16 jul 2026, 23:36 UTC

News

T-Mobile US Inc. experienced routine after-market trading with little change since Thursday's close, maintaining its focus on versatile mobile internet plans.

16 jul 2026, 23:31 UTC

News
Correlated Moves

Micron Technology shares declined in after-market trading amid negative sentiment in the tech sector and concerns over rising capital costs from TSMC.

16 jul 2026, 23:21 UTC

News
Social Media

PayPal Holdings Inc. shares are lower in after-market hours as its board deems a $53 billion takeover bid from Stripe inadequate amid broader market declines.

16 jul 2026, 23:16 UTC

Correlated Moves
News

Intuit Inc shares are lower in after-market trading following a class action lawsuit alleging overstated revenue growth and competitive advantages. Concerns about layoffs persist.

16 jul 2026, 23:16 UTC

News
Social Media

Alphabet Inc shares are higher in after-market trading, rebounding from earlier session lows. Concerns persist over delays in the rollout of its Gemini AI.

16 jul 2026, 23:06 UTC

News

United Airlines Holdings Inc shares are lower in after-market hours, reflecting broader market declines amid concerns over major tech stocks and geopolitical risks.

16 jul 2026, 23:02 UTC

News
Social Media

Intuitive Surgical shares fell in after-market trading despite strong earnings, as management cited U.S. market challenges and a Class II recall of surgical components.

16 jul 2026, 23:01 UTC

News

Escalating military tensions in the Middle East are impacting the United States Oil Fund LP, which is trading lower during after-market hours.

16 jul 2026, 23:01 UTC

News
ETF Constituents
Correlated Moves
Macro News

Vanguard Information Technology ETF declines after major indices drop, led by weakness in semiconductor stocks and a significant decline in Netflix shares.

16 jul 2026, 23:01 UTC

News

Fiserv Inc. shares are lower in after-market trading amid operational challenges, including a 2% revenue decline and a significant drop in operating income.

16 jul 2026, 20:07 UTC

News

Spot silver prices are higher today, despite earlier pulling back from a session high, amid escalating U.S.-Iran tensions and rising inflation concerns.

16 jul 2026, 20:07 UTC

News
Correlated Moves

CHF/HKD is trading lower as initial jobless claims fall to a two-month low, indicating labor market strength amid rising geopolitical tensions.

16 jul 2026, 20:06 UTC

News
Correlated Moves

Gold prices are lower as inflation risks rise amid the U.S.-Iran conflict. Earlier, gold peaked at $3,992.10 per ounce before declining.

16 jul 2026, 20:06 UTC

News
Correlated Moves

Spot silver prices are declining amid rising U.S.-Iran tensions and inflation concerns, currently trading around $56.82 per ounce. Gold also fell sharply today.

16 jul 2026, 20:06 UTC

Macro Event
Correlated Moves
News

Xcel Energy shares are higher, supported by analysts' positive ratings adjustments and a favorable move in the Electric Utilities sub-sector.

16 jul 2026, 20:06 UTC

Correlated Moves
News

Spot silver prices are lower today, trading around $56.82 per ounce amid rising inflation concerns and expectations for Federal Reserve rate hikes.

16 jul 2026, 20:06 UTC

News
Correlated Moves

Spot silver prices are declining amid rising U.S.-Iran tensions and inflation concerns. The metal is trading near $56.82 per ounce, reflecting broader weakness in precious metals.

16 jul 2026, 20:06 UTC

News
Correlated Moves

Spot silver prices are declining amid rising U.S.-Iran tensions and inflation concerns, trading around $56.82 per ounce after a significant drop since Wednesday.

16 jul 2026, 20:06 UTC

Correlated Moves
News

Spot silver prices are lower, trading around $56.82 per ounce amid rising U.S.-Iran tensions and inflation concerns. Gold also declined significantly today.

16 jul 2026, 20:06 UTC

Correlated Moves
News

Spot silver prices are lower today, trading around $56.82 per ounce amid rising inflation concerns and expectations for Federal Reserve rate hikes.

16 jul 2026, 20:06 UTC

Correlated Moves
News

GBP/HKD is trading lower amid the Bank of Korea's interest rate hike to 2.75%. The currency pair reached a session low following early gains.

16 jul 2026, 20:03 UTC

Correlated Moves
News

Wedbush initiated coverage on Verisign with an Outperform rating. Shares are gaining today, reflecting positive sentiment after closing at $268.85.

16 jul 2026, 20:03 UTC

News

O'Reilly Automotive advances amid speculation of a $10 billion acquisition of Genuine Parts' auto parts unit, with analysts citing potential benefits despite FTC review concerns.

16 jul 2026, 20:03 UTC

Correlated Moves
Social Media
News

Qualcomm Inc shares are lower as the semiconductor sector faces pressure from Micron Technology's supply agreements and a notable decline in the Nasdaq 100 Index.

16 jul 2026, 20:02 UTC

News

Align Technology Inc. reported first-quarter revenue of $1.00 billion, slightly above expectations, but shares are lower amid broader market unease and geopolitical tensions.

16 jul 2026, 19:56 UTC

News
Social Media

Expedia Group shares rise after Wedbush initiated coverage with an Outperform rating and a price target of $334, indicating growth potential.

Peer Vergelijking

Prijswijziging

Roivant Sciences Ltd Prognose

Koersdoel

By TipRanks

3.5% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 36.11 USD  3.5%

Hoogste 42 USD

Laagste 29.29 USD

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor Roivant Sciences Ltd - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

7 ratings

6

Buy

1

Hold

0

Sell

Sentiment

By Acuity

59 / 342 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Roivant Sciences Ltd

Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies focusing on biopharmaceutical businesses, discovery-stage companies, and health technology startups. It offers VTAMA, a novel topical approved for the treatment of psoriasis and in development for the treatment of atopic dermatitis; IMVT-1402 and batoclimab, which are fully human monoclonal antibodies that targets the neonatal Fc receptor in development across various IgG-mediated autoimmune indications; brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis and non-infectious uveitis, as well as for other therapies in various stages of clinical development; and Namilumab, a fully human anti-GM-CSF monoclonal antibody under Phase 2 clinical trial for the treatment of inflammatory and autoimmune diseases. The company also provides delivery platforms comprising lipid nanoparticle platform and ligand conjugate platform. It has collaboration and license agreements with Boehringer Ingelheim International, GmbH for conducting discovery work on RNA-specific adenosine deaminase 1 targeting and modulating compounds; and with Japan Tobacco Inc. for the rights to develop, register, and market tapinarof in Japan for the treatment of psoriasis and atopic dermatitis. The company was founded in 2014 and is based in London, the United Kingdom.
help-icon Live chat